11/15
Cancer Research
Abramson Cancer Center receives $10.7 million to study CAR T cells in solid tumors
Abramson Cancer Center receives $10.7 million to study CAR T cells in solid tumors
A new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center of Excellence for Lung Cancer Immunology for experimental approaches in lung cancer and mesothelioma.
Skin cream use OK’d during radiation therapy
Skin cream use OK’d during radiation therapy
A new study challenges common advice given to patients about whether topical creams increase radiation dose during cancer treatment.
Blood test identifies more treatable cancer mutations than biopsies alone
Blood test identifies more treatable cancer mutations than biopsies alone
A new study shows patients with treatable mutations identified by liquid biopsies rather than tissue biopsies also largely respond to therapy.
‘Cancer in all forms is our enemy’
‘Cancer in all forms is our enemy’
Robert H. Vonderheide, the Abramson Cancer Center director, talks innovation, discoveries, FDA approvals, and how to deliver top-of-the-line cancer care.
Immune cells involved in triple-negative breast cancer could offer future therapeutic target
Immune cells involved in triple-negative breast cancer could offer future therapeutic target
New research led by Rumela Chakrabarti reveals how immune cells called myeloid-derived immunosuppressor cells contribute to the progression of triple-negative breast cancer, a particularly aggressive cancer. Pairing chemotherapy with a drug that blocks these cells may one day help stem its growth.
Cutting-edge science moves to the clinic to help ‘our furry friends’ fight cancer
Cutting-edge science moves to the clinic to help ‘our furry friends’ fight cancer
A year after its launch, the Penn Vet Cancer Center is solidifying the translational science pipeline, connecting basic scientists to the clinic and vice versa, to transform veterinary cancer care.
Discovering a single cell that leads to relapse
Discovering a single cell that leads to relapse
Research from the Abramson Cancer Center identified a single leukemic cell, engineered for CAR T therapy, that caused a deadly recurrence of pediatric B-cell acute lymphoblastic leukemia.
DNA vaccine leads to immune responses in HPV-related head and neck cancer
DNA vaccine leads to immune responses in HPV-related head and neck cancer
Researchers from the Abramson Cancer Center find immunotherapy approach can help T cells infiltrate tumors.
CAR T cell therapy receives approval for use across European Union
CAR T cell therapy receives approval for use across European Union
The European Commission has approved a personalized cellular therapy developed at the Abramson Cancer Center, making it the first CAR T cell therapy permitted for use in the European Union in two distinct indications.
Penn Medicine’s Carl June receives 2018 Albany Prize
Penn Medicine’s Carl June receives 2018 Albany Prize
Carl June, a gene therapy pioneer at the Abramson Cancer Center, will receive the 2018 Albany Medical Center Prize in Medicine and Biomedical Research.
In the News
Forbes
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Philadelphia Inquirer
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
PhillyVoice
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
The New York Times
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
Today
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →
Stat
New immunotherapy combination could ‘change the landscape’ of cancer treatment
A study by Andy Minn and postdoc Divij Mathew of the Perelman School of Medicine and colleagues found that a combination checkpoint inhibitor therapy benefited patients with lung cancer.
FULL STORY →